|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol. |
| 公司地址
| 265 Talbot Street West, Leamington, ON, CAN, N8H 5L4 |
| 電話號碼
| +1 844 845-7291 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tilray.com |
| 員工數量
| 2842 |
| Mr. Mitchell S. Gendel |
Global General Counsel and Corporate Secretary |
美元 579.60K |
26/09/2025 |
| Mr. Carl Merton |
Chief Financial Officer and Principal Accounting Officer |
美元 395.88K |
26/09/2025 |
| Ms. Denise M. Faltischek |
Chief Strategy Officer and Head, International |
美元 621.00K |
26/09/2025 |
| Mr. Roger Savell |
Chief Administrative Officer |
美元 543.40K |
26/09/2025 |
| Mr. Irwin D. Simon |
President, Chairman of the Board and Chief Executive Officer |
美元 1.99M |
26/09/2025 |
|
|
| Ms. Renah Persofsky |
Vice Chairman of the Board and Lead Independent Director |
26/09/2025 |
| Mr. David G. Hopkinson |
Independent Director |
26/09/2025 |
| Mr. Thomas Looney |
Independent Director |
26/09/2025 |
| Mr. John M. Herhalt |
Independent Director |
26/09/2025 |
| Ms. Jodi Butts |
Independent Director |
26/09/2025 |
| Mr. Steven M. Cohen |
Independent Director |
26/09/2025 |
| Mr. Irwin D. Simon |
President, Chairman of the Board and Chief Executive Officer |
26/09/2025 |
| Mr. David F. Clanachan |
Independent Director |
26/09/2025 |
|
|
|
|
